TARDBP and amyotrophic lateral sclerosis: Genetic ablation of HOIP or treatment with a LUBAC inhibitor, HOIPIN-8, suppressed the cytoplasmic aggregation of TDP-43, which eliminates TNFα mediated NF-κB activity and ameliorates TDP-43 induced ALS [59].